SPECIAL NOTICE
A -- Notice of Intent to Sole Source
- Notice Date
- 6/5/2025 12:57:02 PM
- Notice Type
- Special Notice
- NAICS
- 541714
— Research and Development in Biotechnology (except Nanobiotechnology)
- Contracting Office
- HEALTH AND HUMAN SERVICES, DEPARTMENT OF Washington DC 20201 US
- ZIP Code
- 20201
- Solicitation Number
- FDA-1284766
- Response Due
- 6/16/2025 12:00:00 PM
- Archive Date
- 06/17/2025
- Point of Contact
- Rodney D. Aytch, Phone: 2404027514
- E-Mail Address
-
rodney.aytch@fda.hhs.gov
(rodney.aytch@fda.hhs.gov)
- Small Business Set-Aside
- NONE No Set aside used
- Description
- The objective of the contract is to obtain Human Induced Pluripotent Stem Cell-Derived Cells. These cells will provide the FDA with the required material to support MPS studies. The cells will enable scientific capabilities consistent with the mission of the Center for Drug Evaluation and Research (CDER).
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/2d472891df0849d8a95445c03c94ee7d/view)
- Place of Performance
- Address: Silver Spring, MD 20993, USA
- Zip Code: 20993
- Country: USA
- Zip Code: 20993
- Record
- SN07466840-F 20250607/250605230047 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |